Evaluation of antibiotic prescribing patterns in patients receiving sustained low-efficiency dialysis

Opportunities for pharmacists

Laura E. Harris, Anne Reaves, Amy G. Krauss, Justin Griner, Joanna Laizure

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objectives Sustained low-efficiency dialysis (SLED) is a 'hybrid' form of continuous renal replacement therapy; however, there is very limited information on drug disposition during this procedure. Individuals requiring SLED are often critically ill and require antibiotics. The study aim was to evaluate antibiotic orders for patients requiring SLED compared to literature-based recommendations. We also evaluated whether doses were administered as prescribed and assessed clinical and microbiologic cure. Methods A retrospective review was performed over a 2-year period for patients who received concurrent SLED and antibiotic therapy. Demographic data, prescribed antibiotic dosing regimens and doses delivered as prescribed were determined for 10 antibiotics: cefepime (C), daptomycin (Da), doripenem (D), gentamicin (G), imipenem-cilastatin (I), linezolid (L), meropenem (M), piperacillin-tazobactam (P), tobramycin (T) and vancomycin (V). Dosing regimens were compared to recommendations from the literature where available. The incidence of clinical and microbiologic cure was also evaluated. Results A total of 87 patients met inclusion criteria: mean age 54 ± 14 years, 60% male, 58% white. Prescribed doses were evidence-based for 37% of Da, 97% of L, 15% of M and 7% of V orders. The majority of discrepancies were due to under-dosing. There were 129 (11%) antibiotic doses missed. Of the 13 patients who met criteria for assessment of clinical and microbiologic cure, 10 achieved a microbiologic cure and none reached clinical cure. Conclusions Prescribed antibiotic dosing regimens varied substantially and under-dosing was common. There is a need to further define appropriate dosing regimens for antibiotics administered during SLED and determine how pharmacists may help to ensure appropriate therapy.

Original languageEnglish (US)
Pages (from-to)55-61
Number of pages7
JournalInternational Journal of Pharmacy Practice
Volume21
Issue number1
DOIs
StatePublished - Feb 1 2013

Fingerprint

Dialysis
Pharmacists
Anti-Bacterial Agents
Daptomycin
Linezolid
meropenem
doripenem
Tobramycin
Renal Replacement Therapy
Vancomycin
Gentamicins
Critical Illness
Demography
Incidence
Therapeutics
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmaceutical Science
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Evaluation of antibiotic prescribing patterns in patients receiving sustained low-efficiency dialysis : Opportunities for pharmacists. / Harris, Laura E.; Reaves, Anne; Krauss, Amy G.; Griner, Justin; Laizure, Joanna.

In: International Journal of Pharmacy Practice, Vol. 21, No. 1, 01.02.2013, p. 55-61.

Research output: Contribution to journalArticle

@article{00cc277adff0475b809ce170db5af8bc,
title = "Evaluation of antibiotic prescribing patterns in patients receiving sustained low-efficiency dialysis: Opportunities for pharmacists",
abstract = "Objectives Sustained low-efficiency dialysis (SLED) is a 'hybrid' form of continuous renal replacement therapy; however, there is very limited information on drug disposition during this procedure. Individuals requiring SLED are often critically ill and require antibiotics. The study aim was to evaluate antibiotic orders for patients requiring SLED compared to literature-based recommendations. We also evaluated whether doses were administered as prescribed and assessed clinical and microbiologic cure. Methods A retrospective review was performed over a 2-year period for patients who received concurrent SLED and antibiotic therapy. Demographic data, prescribed antibiotic dosing regimens and doses delivered as prescribed were determined for 10 antibiotics: cefepime (C), daptomycin (Da), doripenem (D), gentamicin (G), imipenem-cilastatin (I), linezolid (L), meropenem (M), piperacillin-tazobactam (P), tobramycin (T) and vancomycin (V). Dosing regimens were compared to recommendations from the literature where available. The incidence of clinical and microbiologic cure was also evaluated. Results A total of 87 patients met inclusion criteria: mean age 54 ± 14 years, 60{\%} male, 58{\%} white. Prescribed doses were evidence-based for 37{\%} of Da, 97{\%} of L, 15{\%} of M and 7{\%} of V orders. The majority of discrepancies were due to under-dosing. There were 129 (11{\%}) antibiotic doses missed. Of the 13 patients who met criteria for assessment of clinical and microbiologic cure, 10 achieved a microbiologic cure and none reached clinical cure. Conclusions Prescribed antibiotic dosing regimens varied substantially and under-dosing was common. There is a need to further define appropriate dosing regimens for antibiotics administered during SLED and determine how pharmacists may help to ensure appropriate therapy.",
author = "Harris, {Laura E.} and Anne Reaves and Krauss, {Amy G.} and Justin Griner and Joanna Laizure",
year = "2013",
month = "2",
day = "1",
doi = "10.1111/j.2042-7174.2012.00226.x",
language = "English (US)",
volume = "21",
pages = "55--61",
journal = "International Journal of Pharmacy Practice",
issn = "0961-7671",
publisher = "Pharmaceutical Press",
number = "1",

}

TY - JOUR

T1 - Evaluation of antibiotic prescribing patterns in patients receiving sustained low-efficiency dialysis

T2 - Opportunities for pharmacists

AU - Harris, Laura E.

AU - Reaves, Anne

AU - Krauss, Amy G.

AU - Griner, Justin

AU - Laizure, Joanna

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Objectives Sustained low-efficiency dialysis (SLED) is a 'hybrid' form of continuous renal replacement therapy; however, there is very limited information on drug disposition during this procedure. Individuals requiring SLED are often critically ill and require antibiotics. The study aim was to evaluate antibiotic orders for patients requiring SLED compared to literature-based recommendations. We also evaluated whether doses were administered as prescribed and assessed clinical and microbiologic cure. Methods A retrospective review was performed over a 2-year period for patients who received concurrent SLED and antibiotic therapy. Demographic data, prescribed antibiotic dosing regimens and doses delivered as prescribed were determined for 10 antibiotics: cefepime (C), daptomycin (Da), doripenem (D), gentamicin (G), imipenem-cilastatin (I), linezolid (L), meropenem (M), piperacillin-tazobactam (P), tobramycin (T) and vancomycin (V). Dosing regimens were compared to recommendations from the literature where available. The incidence of clinical and microbiologic cure was also evaluated. Results A total of 87 patients met inclusion criteria: mean age 54 ± 14 years, 60% male, 58% white. Prescribed doses were evidence-based for 37% of Da, 97% of L, 15% of M and 7% of V orders. The majority of discrepancies were due to under-dosing. There were 129 (11%) antibiotic doses missed. Of the 13 patients who met criteria for assessment of clinical and microbiologic cure, 10 achieved a microbiologic cure and none reached clinical cure. Conclusions Prescribed antibiotic dosing regimens varied substantially and under-dosing was common. There is a need to further define appropriate dosing regimens for antibiotics administered during SLED and determine how pharmacists may help to ensure appropriate therapy.

AB - Objectives Sustained low-efficiency dialysis (SLED) is a 'hybrid' form of continuous renal replacement therapy; however, there is very limited information on drug disposition during this procedure. Individuals requiring SLED are often critically ill and require antibiotics. The study aim was to evaluate antibiotic orders for patients requiring SLED compared to literature-based recommendations. We also evaluated whether doses were administered as prescribed and assessed clinical and microbiologic cure. Methods A retrospective review was performed over a 2-year period for patients who received concurrent SLED and antibiotic therapy. Demographic data, prescribed antibiotic dosing regimens and doses delivered as prescribed were determined for 10 antibiotics: cefepime (C), daptomycin (Da), doripenem (D), gentamicin (G), imipenem-cilastatin (I), linezolid (L), meropenem (M), piperacillin-tazobactam (P), tobramycin (T) and vancomycin (V). Dosing regimens were compared to recommendations from the literature where available. The incidence of clinical and microbiologic cure was also evaluated. Results A total of 87 patients met inclusion criteria: mean age 54 ± 14 years, 60% male, 58% white. Prescribed doses were evidence-based for 37% of Da, 97% of L, 15% of M and 7% of V orders. The majority of discrepancies were due to under-dosing. There were 129 (11%) antibiotic doses missed. Of the 13 patients who met criteria for assessment of clinical and microbiologic cure, 10 achieved a microbiologic cure and none reached clinical cure. Conclusions Prescribed antibiotic dosing regimens varied substantially and under-dosing was common. There is a need to further define appropriate dosing regimens for antibiotics administered during SLED and determine how pharmacists may help to ensure appropriate therapy.

UR - http://www.scopus.com/inward/record.url?scp=84872254198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872254198&partnerID=8YFLogxK

U2 - 10.1111/j.2042-7174.2012.00226.x

DO - 10.1111/j.2042-7174.2012.00226.x

M3 - Article

VL - 21

SP - 55

EP - 61

JO - International Journal of Pharmacy Practice

JF - International Journal of Pharmacy Practice

SN - 0961-7671

IS - 1

ER -